PlenSat is a medical device Company developing a new approach to obesity control. The Company has created a new device, The Digestible Balloon, which the Company believes will provide the benefits of bariatric surgery (stomach stapling, stomach banding, gastric bypass, and gastric balloon insertion) without invasive procedures. Digestible Balloons will potentially allow the treatment of patients suffering from obesity and overweight with an easy to use and reversible technology that can be made available to the large number of patients in need.
The need is overwhelming as obesity and overweight have been shown to lead to Type 2 Diabetes and prediabetes in many patients. Weight loss and proper nutrition are key components of Diabetes care, as well as being central to prevention of type 2 diabetes, and to the emerging concept of type 2 diabetes remission or reversal. (Editorial, Lancet Diabetes and Endocrinology, 7 p433, June 2019)
The concept behind this is simple. Space filling devices and space constricting devices have been shown to be effective in some patients at controlling their appetite by inducing a feeling of fullness. PlenSat believes that the use of easily swallowed, safe food based devices will make this therapy more widely available.